Skip to main content
SpringerLink
Log in

Emerging the Notion and Definition of NHCAP: What Is the NHCAP? Why Aspiration Pneumonia Is Important in NHCAP?

  • Chapter
  • First Online:
Aspiration Pneumonia

  • 1158 Accesses

Abstract

Healthcare-associated pneumonia (HCAP) overlapped both community-acquired pneumonia (CAP) and hospital-acquired pneumonia (HAP), since most cases of HCAP in Japan are diagnosed as “aspiration pneumonia” in the elderly persons who are receiving nursing care. Therefore, a separating category and term are recommended as “nursing- and healthcare-associated pneumonia (NHCAP).” The treatment by antibiotics should be used carefully to prevent the undesired care and antimicrobial resistance, and the care including vaccination and infection control should have priority rather than cure in the management of NHCAP patients, including most aspiration pneumonia patients in Japan.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Kohno S, Imamura Y, Shindo Y, et al. Clinical practice guidelines for nursing- and healthcare-associated pneumonia (NHCAP). Respir Investig. 2013;53:103–26.

    Article  Google Scholar 

  2. The committee for the Japanese Respiratory Society guidelines in the management of respiratory infections. The Japanese respiratory society guidelines for the management of community-acquired pneumonia in adults. Respirology. 2006;11:S1–S133.

    Article  Google Scholar 

  3. The committee for the Japanese Respiratory Society guidelines for the management of respiratory infections. The Japanese Respiratory society guidelines for the management of hospital-acquired pneumonia in adults 2008. Respirology. 2009;14:S1–71.

    Article  Google Scholar 

  4. American Thoracic Society and Infectious Diseases Society of America. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med. 2005;171:388–416.

    Article  Google Scholar 

  5. Kollef MH, Morrow LE, Baughman RP, et al. Health care-associated pneumonia (HCAP): a critical appraisal to improve identification, management, and outcomes—proceedings of the HCAP summit. Clin Infect Dis. 2008;46:S296–334.

    Article  Google Scholar 

  6. Shindo Y, Sato S, Maruyama E, et al. Health-care-associated pneumonia among hospitalized patients in a Japanese community hospital. Chest. 2009;135:633–40.

    Article  Google Scholar 

  7. Seki M, Hashiguchi K, Tanaka A, et al. Characteristics and disease severity of healthcare-associated pneumonia among patients in a hospital in Kitakyushu Jpn. J Infect Chemother. 2011;17:363–9.

    Article  Google Scholar 

  8. Maruyama T, Niederman MS, Kobayashi T, et al. A prospective comparison of nursing home-acquired pneumonia with hospital-acquired pneumonia in non-intubated elderly. Respir Med. 2008;102:1287–95.

    Article  CAS  Google Scholar 

  9. Brito V, Niederman MS. Healthcare-associated pneumonia is a heterogeneous disease, and all patients do not need the same broad-spectrum antibiotic therapy as complex nosocomial pneumonia. Curr Opin Infect Dis. 2009;22:316–25.

    Article  Google Scholar 

  10. Ewig S, Welte T, Chastre J, et al. Rethinking the concepts of community-acquired and health-care-associated pneumonia. Lancet Infect Dis. 2010;10:279–87.

    Article  Google Scholar 

  11. Carratalà J, Mykietiuk A, Fernández-Sabé N, et al. Health care-associated pneumonia requiring hospital admission: epidemiology, antibiotic therapy, and clinical outcomes. Arch Intern Med. 2007;167:1393–9.

    Article  Google Scholar 

  12. Seki M, Watanabe A, Mikasa K, Kadota J, Kohno S. Revision of the severity rating and classification of hospital-acquired pneumonia in the Japanese respiratory society guidelines. Respirology. 2008;13:880–8.

    Article  Google Scholar 

  13. Teramoto S, Kawashima M, Komiya K, et al. Health-care-associated pneumonia may be primary due to aspiration pneumonia. Chest. 2009;136:1702–3.

    Article  Google Scholar 

  14. Seki M, Yanagihara K, Higashiyama Y, Fukuda Y, Kaneko Y, Ohno H, Miyazaki Y, Hirakata Y, Tomono K, Kadota J, Tashiro T, Kohno S. Immunokinetics in severe pneumonia due to influenza virus and bacteria coinfection in mice. Eur Respir J. 2004;24:143–9.

    Article  CAS  Google Scholar 

  15. Maruyama T, Taguchi O, Niederman MS, et al. Efficacy of 23-valent pneumococcal vaccine in preventing pneumonia and improving survival in nursing home residents: double blind, randomized and placebo controlled trial. Br Med J. 2010;340:c1104.

    Article  Google Scholar 

  16. Huijts SM, Coenjaerts FEJ, Bolkenbaas M, van Werkhoven CH, Grobbee DE, Bonten MJM. CAPiTA study team. The impact of 13-valent pneumococcal conjugate vaccination on virus-associated community-acquired pneumonia in elderly: exploratory analysis of the CAPiTA trial. Clin Microbiol Infect. 2018;24(7):764–70.

    Article  CAS  Google Scholar 

  17. Kawakami K, Ohkusa Y, Kuroki R, et al. Effectiveness of pneumococcal polysaccharide vaccine against pneumonia and cost analysis for the elderly who receive seasonal influenza vaccine in Japan. Vaccine. 2010;28:7063–9.

    Article  Google Scholar 

  18. Maeda M, Muraki Y, Kosaka T, Yamada T, Aoki Y, Kaku M, Kawaguchi T, Seki M, Tanabe Y, Fujita N, Morita K, Yanagihara K, Yoshida K, Niki Y. The first nationwide survey of antimicrobial stewardship programs conducted by the Japanese Society of Chemotherapy. J Infect Chemother. 2019;25:83–8. https://doi.org/10.1016/j.jiac.2018.11.001.

    Article  PubMed  Google Scholar 

  19. Miyawaki K, Miwa M, Seki M, Asari S, Tomono K, Kurokawa N. Correlation between the consumption of meropenem or doripenem and meropenem susceptibility of Pseudomonas aeruginosa in a university hospital in Japan. Biol Pharm Bull. 2012;35:946–9.

    Article  CAS  Google Scholar 

  20. Seki M, Watanabe Y. The microbiological effects of antimicrobial stewardship program and infection control in Japan. J Prev Infect Cntrol. 2017;3(2):9. https://doi.org/10.21767/2471-9668.100034.

    Article  Google Scholar 

  21. Watanabe Y, Seki M. Improvement of antibiotics susceptibility of Escherichia coli in a tertiary hospital in Japan. Microbiol Res J Int. 2019;28(1):1–5.

    Article  Google Scholar 

Download references

Acknowledgments

This work was supported by a Grant-in-Aid for Scientific Research (17 K09623 to M.S.) from the Japanese Society for the Promotion of Science.

Author information

Authors and Affiliations

  1. Division of Infectious Diseases and Infection Control, Faculty of Medicine, Tohoku Medical and Pharmaceutical University, Sendai, Miyagi, Japan

    Masafumi Seki

Authors
  1. Masafumi Seki
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Masafumi Seki .

Editor information

Editors and Affiliations

  1. Department of Respiratory Medicine, Tokyo Medical University Hachioji Medical Center, Tokyo, Japan

    Shinji Teramoto

  2. Respiratory Medicine & Infectious Diseases, Oita University Faculty of Medicine, Yufu, Oita, Japan

    Kosaku Komiya

Ethics declarations

None.

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Seki, M. (2020). Emerging the Notion and Definition of NHCAP: What Is the NHCAP? Why Aspiration Pneumonia Is Important in NHCAP?. In: Teramoto, S., Komiya, K. (eds) Aspiration Pneumonia. Respiratory Disease Series: Diagnostic Tools and Disease Managements. Springer, Singapore. https://doi.org/10.1007/978-981-15-4506-1_21

Download citation

  • DOI: https://doi.org/10.1007/978-981-15-4506-1_21

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-15-4505-4

  • Online ISBN: 978-981-15-4506-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation